Katherine B. Geiersbach

937 total citations
44 papers, 619 citations indexed

About

Katherine B. Geiersbach is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Katherine B. Geiersbach has authored 44 papers receiving a total of 619 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Oncology, 18 papers in Molecular Biology and 13 papers in Cancer Research. Recurrent topics in Katherine B. Geiersbach's work include HER2/EGFR in Cancer Research (11 papers), Cancer Genomics and Diagnostics (10 papers) and Monoclonal and Polyclonal Antibodies Research (6 papers). Katherine B. Geiersbach is often cited by papers focused on HER2/EGFR in Cancer Research (11 papers), Cancer Genomics and Diagnostics (10 papers) and Monoclonal and Polyclonal Antibodies Research (6 papers). Katherine B. Geiersbach collaborates with scholars based in United States, Italy and Canada. Katherine B. Geiersbach's co-authors include Wade S. Samowitz, Sheryl R. Tripp, Michelle L. Wallander, Christian N. Paxton, Lester J. Layfield, Erinn Downs‐Kelly, Elke A. Jarboe, Mary P. Bronner, D. Ware Branch and Robert M. Silver and has published in prestigious journals such as SHILAP Revista de lepidopterología, Cancer Research and Clinical Chemistry.

In The Last Decade

Katherine B. Geiersbach

42 papers receiving 607 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Katherine B. Geiersbach United States	15	235	192	165	162	137	44	619
Alexis Norris-Kirby United States	7	163 0.7×	184 1.0×	87 0.5×	149 0.9×	96 0.7×	7	490
Annet Simons Netherlands	17	144 0.6×	239 1.2×	145 0.9×	96 0.6×	154 1.1×	29	800
Kenji Umayahara Japan	16	129 0.5×	164 0.9×	119 0.7×	112 0.7×	67 0.5×	41	828
Michael Neat United Kingdom	18	259 1.1×	493 2.6×	104 0.6×	89 0.5×	298 2.2×	38	1.1k
Seiryu Kamoi Japan	12	132 0.6×	136 0.7×	81 0.5×	71 0.4×	61 0.4×	33	745
Mark A. Micale United States	14	105 0.4×	259 1.3×	248 1.5×	197 1.2×	150 1.1×	32	689
Nancy Boeckx Belgium	17	146 0.6×	313 1.6×	49 0.3×	104 0.6×	110 0.8×	56	973
Natalie Banet United States	11	135 0.6×	152 0.8×	73 0.4×	44 0.3×	42 0.3×	33	519
Ming-Chieh Lin Taiwan	18	153 0.7×	242 1.3×	57 0.3×	90 0.6×	120 0.9×	35	706
Amnon Amit Israel	10	408 1.7×	237 1.2×	41 0.2×	55 0.3×	48 0.4×	31	739

Countries citing papers authored by Katherine B. Geiersbach

Since Specialization

Citations

This map shows the geographic impact of Katherine B. Geiersbach's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katherine B. Geiersbach with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katherine B. Geiersbach more than expected).

Fields of papers citing papers by Katherine B. Geiersbach

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katherine B. Geiersbach. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katherine B. Geiersbach. The network helps show where Katherine B. Geiersbach may publish in the future.

Co-authorship network of co-authors of Katherine B. Geiersbach

This figure shows the co-authorship network connecting the top 25 collaborators of Katherine B. Geiersbach. A scholar is included among the top collaborators of Katherine B. Geiersbach based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katherine B. Geiersbach. Katherine B. Geiersbach is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pitel, Beth A., Saba Alvand, Carlos Sosa, et al.. (2025). Evaluation of Atypical Fluorescence in Situ Hybridization Findings by RNA Sequencing. Journal of Molecular Diagnostics. 27(11). 1098–1114.

Sukov, William R., Jain Zhou, Katherine B. Geiersbach, et al.. (2023). Frequency of HER2 protein overexpression and HER2 gene amplification in endometrial clear cell carcinoma. Human Pathology. 137. 94–101. 5 indexed citations

Geiersbach, Katherine B., Troy J. Gliem, Athanasios Gaitatzes, et al.. (2022). Single-Nucleotide Polymorphism Array for Histologically Ambiguous Melanocytic Tumors. Journal of Molecular Diagnostics. 24(11). 1160–1170. 4 indexed citations

Geiersbach, Katherine B., Reid G. Meyer, Grant M. Spears, et al.. (2021). Detailed Reanalysis of 500 Breast Cancers With Equivocal HER2 Immunohistochemistry and Borderline ERBB2 Fluorescence In Situ Hybridization Results. American Journal of Clinical Pathology. 156(5). 886–894. 1 indexed citations

Zhao, Yiqing, Kevin C. Halling, Benjamin R. Kipp, et al.. (2021). Assessment of RAS Dependency for BRAF Alterations Using Cancer Genomic Databases. JAMA Network Open. 4(1). e2035479–e2035479. 8 indexed citations

Geiersbach, Katherine B., Reid G. Meyer, William R. Sukov, et al.. (2020). HER2 Testing for Breast Cancer in the Genomics Laboratory: A Sea Change for Fluorescence In Situ Hybridization. Archives of Pathology & Laboratory Medicine. 145(7). 883–886. 3 indexed citations

Geiersbach, Katherine B., Hui Chen, Rajyasree Emmadi, et al.. (2020). Current concepts in breast cancer genomics: An evidence based review by the CGC breast cancer working group. Cancer Genetics. 244. 11–20. 5 indexed citations

Geiersbach, Katherine B., Julia A. Bridge, Michelle Dolan, et al.. (2018). Comparative Performance of Breast Cancer Human Epidermal Growth Factor Receptor 2 Fluorescence In Situ Hybridization and Brightfield In Situ Hybridization on College of American Pathologists Proficiency Tests. Archives of Pathology & Laboratory Medicine. 142(10). 1254–1259. 1 indexed citations

Vasmatzis, George, Xue Wang, James B. Smadbeck, et al.. (2018). Chromoanasynthesis is a common mechanism that leads to ERBB2 amplifications in a cohort of early stage HER2+ breast cancer samples. BMC Cancer. 18(1). 738–738. 14 indexed citations

10.

Ross, Jeffrey S., Christine E. Sheehan, Kajsa E. Affolter, et al.. (2017). PD-L1 protein expression in tumour cells and immune cells in mismatch repair protein-deficient and -proficient colorectal cancer: the foundation study using the SP142 antibody and whole section immunohistochemistry. Journal of Clinical Pathology. 71(1). 46–51. 18 indexed citations

11.

Stewart, Rachel L., et al.. (2017). HER2 immunohistochemical and fluorescence in situ hybridization discordances in invasive breast carcinoma with micropapillary features. Modern Pathology. 30(11). 1561–1566. 21 indexed citations

12.

Willmore‐Payne, Carlynn, et al.. (2016). Inconsistent Results With Different Secondary Reflex Assays for ResolvingHER2Status. American Journal of Clinical Pathology. 146(5). 618–626. 5 indexed citations

13.

Ling, Hui, Katherine B. Geiersbach, Erinn Downs‐Kelly, & H. Evin Gulbahce. (2016). RAI1 Alternate Probe Identifies Additional Breast Cancer Cases as Amplified Following Equivocal HER2 Fluorescence In Situ Hybridization Testing: Experience From a National Reference Laboratory. Archives of Pathology & Laboratory Medicine. 141(2). 274–278. 11 indexed citations

14.

Geiersbach, Katherine B., Carlynn Willmore‐Payne, Christian N. Paxton, et al.. (2016). Genomic Copy Number Analysis ofHER2-Equivocal Breast Cancers. American Journal of Clinical Pathology. 146(4). 439–447. 4 indexed citations

15.

Zhou, Wenhua, Katherine B. Geiersbach, & Barbara Chadwick. (2016). Rapid removal of cytology slide coverslips for DNA and RNA isolation. Journal of the American Society of Cytopathology. 6(1). 24–27. 12 indexed citations

16.

Geiersbach, Katherine B., et al.. (2014). Differentiation of genetic abnormalities in early pregnancy loss. Ultrasound in Obstetrics and Gynecology. 45(1). 89–94. 39 indexed citations

17.

Wilkerson, Matthew D., D. Neil Hayes, Patrick J. Roberts, et al.. (2013). Prediction of Lung Cancer Histological Types by RT-qPCR Gene Expression in FFPE Specimens. Journal of Molecular Diagnostics. 15(4). 485–497. 16 indexed citations

18.

Adey, Nils B., et al.. (2013). A mill based instrument and software system for dissecting slide-mounted tissue that provides digital guidance and documentation. BMC Clinical Pathology. 13(1). 29–29. 8 indexed citations

19.

Geiersbach, Katherine B., Elke A. Jarboe, Mona S. Jahromi, et al.. (2011). FOXL2 mutation and large-scale genomic imbalances in adult granulosa cell tumors of the ovary. Cancer Genetics. 204(11). 596–602. 23 indexed citations

20.

Dames, Shale, et al.. (2010). Comparison of the Illumina Genome Analyzer and Roche 454 GS FLX for resequencing of hypertrophic cardiomyopathy-associated genes.. PubMed. 21(2). 73–80. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact